Camber Spine has received US Food and Drug Administration (FDA) 510(k) clearance for both its […]

The trial is the first study to compare interventional therapy in combination with anticoagulation vs. anticoagulation alone for pulmonary embolism.

Beacon MedTech Solutions — formerly Built Rite-Reliance and LSR Engineering — recently announced that it has […]

PepGen has raised $112.5 million to take a treatment for Duchenne muscular dystrophy (DMD) into the clinic […]

A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US […]

Orthofix has announced the first patient implant in a US Food and Drug Administration (FDA) […]

The proceeds will enable the company to complete development and perform its first clinical trial.

The new portal helps collect and offer insights about a patient’s seizure data in real-time. 

​​Rani Therapeutics Holdings ​​(NSDQ:RANI), developer of a robotic drug-delivery pill system, generated $73.3 million in its […]

The artificial intelligence-based technology of Iterative Scopes brings computer vision analysis to endoscopic images. The startup’s technology was initially developed to assist gastroenterologists in finding pre-cancerous polyps but CEO and founder Jonathan Ng said it’s also finding additional use helping pharmaceutical companies identify patients for clinical trials.

Tegra Medical announced that it appointed Darren Vine as its director of sales and marketing […]

Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen […]

A new technology to help surgeons reduce the risk of aneurysm regrowth, Philips’ most recent […]

Zimmer Biomet (NYSE:ZBH) shares slid before hours on second-quarter results that topped the consensus forecast. The […]

IZI Medical has officially launched Vertefix HV Cement, a product which aims to address the […]

Sanofi has struck a deal to buy its mRNA partner Translate Bio in a $3.2 billion deal. […]

The funds will be used to accelerate HMNC’s pipeline development towards market maturity.

Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.

Cayaba Care aims to meet the full scope of maternal health needs by providing home-based and technology-enabled care. 

BioIntelliSense, a startup with backers including UCHealth and Royal Philips, recently raised $45 million.  The company began marketing its sticker-like device to monitor patients’ vitals last year after getting FDA clearance at the end of 2019.

Award will accelerate development of Sense’s rapid, non-invasive brain scanners through clinical testing, to enable objective method of detecting and continuously monitoring traumatic brain injury through transport to field hospital.

Abbott (NYSE:ABT) announced today that it received FDA clearance for its FreeStyle Libre 2 iOS […]

Philips, Endologix and several smaller companies in recent weeks won the regulatory privilege, giving them speedier review of products that may provide more effective treatments for life-threatening conditions.

NuVasive has announced that it has received US Food and Drug Administration 510(k) clearance for […]

Smith+Nephew (LON: SN; NYSE: SNN) saw its sales jump 48% in Q2, with the company reiterating […]

The medtech industry remains on the upswing as companies see their stocks rising with quarterly […]

TransMedics (NSDQ:TMDX) has won FDA clearance of its OCS Lung System to provide hypothermic flushing, storage […]

The company plans to use the money to help expand its pipeline and scale. 

This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.

Tenaya Therapeutics announced that it priced an underwritten, upsized initial public offering of common stock worth […]

Align Technology (NSDQ:ALGN) shares shot up today on second-quarter results that came in ahead of the […]

Edwards Lifesciences (NYSE: EW) reported second-quarter results this evening that beat the consensus forecast on Wall […]

Abbott (NYSE:ABT) announced that it launched the Jot Dx — its latest insertable cardiac monitor (ICM) […]

Antigen test revenue grew more than 200% but is now expected to drop significantly. Unlike rivals like Abbott and Quidel, which have seen fast-falling sales, the German medtech primarily serves Europe.

Dexcom (NSDQ:DXCM) shares ticked up after hours on second-quarter results that topped the consensus forecast. The […]

The financing will fund the commercialization of the company’s handheld ultrasound device and its intuitive point-of-care ultrasound workflow solution, Exo Works.

Neuro42, a US medical technology start-up focused on magnetic resonance imaging (MRI) and robotics, has […]

MedRhythms is developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease.